Please assess the completion status of the following clinical trial:

Trial Title: Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Caucasian female~* Age 40-59 years~* Serum creatinine \< 1.3 and estimated glomerular filtration rate (GRF) \> 60~* Serum calcium in the normal range (for U Md lab 8.6-10 mg/dl)~* Parathyroid hormone in the normal range (for U Md lab 12-54 pg/ml)~* Normal 25-hydroxyvitamin D level (30 ng/ml or higher)~* For women of childbearing age, non-pregnant (based on negative urine pregnancy test on the morning of the teriparatide infusion)~Exclusion Criteria:~* Non-caucasian~* Age under 40 and over 59 years~* Male~* Serum creatinine over 1.3 or estimated glomerular filtration rate (GFR) \< 60~* Abnormal serum calcium (for U Md lab, below 8.6 or above 10 mg/dl)~* Abnormal parathyroid hormone (for U Md lab, above 65 or below 12 pg/ml)~* For women of childbearing age, non-pregnant (based on urine pregnancy test on the morning of the teriparatide infusion)~* History of bone radiation~* History of Paget disease of bone~* History of bone malignancy or metastases~* History of allergy or sensitivity to Forteo

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 59 Years
- Healthy Volunteers: t

Study Arms:
- teriparatide control (Type: ACTIVE_COMPARATOR): control subject
- Teriparatide Patient (Type: EXPERIMENTAL): Patient with secondary hyperparathyroidism

Based on this trial design, predict the completion outcome and termination type (if applicable).